Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 4/20 | 0.72 |
| ▸ | RAB9A | P51151 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | CASP3 | P42574 | 2/20 | 0.72 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.72 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.72 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 5/20 | 0.68 |
| ▸ | GLA | P06280 | 4/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | STS | P08842 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hymecromone Methyl Ether SCHEMBL31103478 | 1.00 | KDM4E (1.00) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| Hymecromone Methyl Ether SCHEMBL27790754 | 0.90 | KDM4E (0.81) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL7115071 | 0.86 | ALDH1A1 (1.00) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL3757479 | 0.85 | ALDH1A1 (0.73) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL16334329 | 0.84 | NPC1 (1.00) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL119380 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL14424527 | 0.84 | KDM4E (0.73) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL28577943 | 0.84 | KDM4E (0.72) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL15842390 | 0.83 | ALDH1A1 (0.71) | KDM4EALDH1A1HSD17B10HPGDNPC1 | |
| SCHEMBL4386227 | 0.83 | KDM4E (0.79) | KDM4EALDH1A1HSD17B10HPGDNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084877-A | Water-soluble fluorescent probe for detecting hypochlorite, and preparation method and application thereof | 绵阳师范学院 | 2024-05-28 | — | — | CN | claimed |
| CN-115032312-B | Method for simultaneously detecting multiple sensitization fragrances in mosquito-repellent product | 浙江省产品质量安全科学研究院 | 2023-10-03 | — | — | CN | claimed |
| CN-116672289-A | Leaf extract of white mustard and application thereof in preparing cosmetics | 西藏藏医药大学 | 2023-09-01 | — | — | CN | claimed |
| CN-115364144-A | Yuqing lobular Kuding tea extract and preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2022-11-22 | — | — | CN | claimed |
| CN-115032312-A | Method for simultaneously detecting multiple allergic aromatics in mosquito repellent product | 浙江省产品质量安全科学研究院 | 2022-09-09 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| US-20080009544-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-01-10 | — | — | US | claimed |
| US-6630581-B2 | Condensing the 3'-OH or 5'-OH group of a support-bound nucleoside or oligonucleotide with a monomeric nucleoside phosphoramidite having a carbonate-protected hydroxyl group; treating the intermediate provided with a deprotecting reagent | AGILENT TECHNOLOGIES, INC. | 2003-10-07 | — | — | US | claimed |
| WO-1994003168-A1 | 5 S PENEM DERIVATIVES, THEIR PREPARATION AND USE | SMITHKLINE BEECHAM PLC (GB) | 1994-02-17 | — | — | WO | claimed |
| EP-0360618-B1 | LIGHT-SENSITIVE COMPOSITION | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-16 | — | — | EP | claimed |
| US-4812362-A | POLYMERIC COATING ON GLASS OR SILICA GEL, CHROMATOGRAPHY | BIO-AFFINITY SYSTEMS, INC. (US) | 1989-03-14 | — | — | US | claimed |
| WO-1989001406-A1 | SOLID PHASE N-HYDROXYSUCCINIMIDE REAGENTS AND USE OF SAME | BIO-AFFINITY SYSTEMS, INC. (US) | 1989-02-23 | — | — | WO | claimed |
| EP-0013910-B1 | THEOPHYLLINE ANTIGENES AND ANTIBODIES, PROCESS FOR THEIR PREPARATION, THEIR USE IN THE DETERMINATION OF THEOPHYLLINE; TEST KIT AND ANTISERUM FOR THIS USE | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1982-12-08 | — | — | EP | claimed |
| US-4302438-A | Antigen, antiserum and immunoassay for theophylline | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1981-11-24 | — | — | US | claimed |
| EP-0013910-A1 | Theophylline antigenes and antibodies, process for their preparation, their use in the determination of theophylline; test kit and antiserum for this use | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1980-08-06 | — | — | EP | claimed |
| JP-60036495-A | — | — | None | — | — | JP | disclosed |
| US-12630804-B2 | Blood brain barrier model | University of Lancashire (GB) | 2026-05-19 | — | — | US | disclosed |
| US-4250053-A | WITH FLUORESCENT COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
| EP-0013910-A1 | Theophylline antigenes and antibodies, process for their preparation, their use in the determination of theophylline; test kit and antiserum for this use | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1980-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009544-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | ACHE, BCHE, CHRNB1 | KDM4E 1482/4885ALDH1A1 1025/4885HSD17B10 457/4885 |
| US-12630804-B2 | Blood brain barrier model | PGF, FLT4, VEGFA | KDM4E 2792/4885ALDH1A1 3389/4885HSD17B10 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.